• Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • NP and PA
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
  • Vitiligo
  • Wound Care

Article

AAD offers MIPS guidance

The American Academy of Dermatology (AAD) is assisting with the Merit-based Incentive Payment System (MIPS) by offering a series of tools that guide users based on customized input.

The American Academy of Dermatology (AAD) is assisting with the Merit-based Incentive Payment System (MIPS) by offering a series of tools that guide users based on customized input.

The MIPS tool created by the AAD include an outline of eligibility and financial requirements in a step-by-step format. The steps include:

#1 MIPS Financial Assessment: Determine whether your practice will have to participate in MIPS to avoid penalties in 2019.

#2 MIPS Reporting – Decision Support: Assess how to participate in MIPS this year, including options for what and how much needs to be reported.

#3 DataDerm – Decision Support: This tool provides DataDerm-specific reporting options, for those practices choosing to report using DataDerm, which is the AAD’s clinical data registry.

#4 Quality Measures Selection: Find eligible measures based on which method your practice chooses to report.

Find more MIPS guidance on the AAD’s website.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

© 2025 MJH Life Sciences

All rights reserved.